| Literature DB >> 34531489 |
Giovanni Boscarino1, Maria Di Chiara1, Raffaella Cellitti1, Maria Chiara De Nardo1, Maria Giulia Conti1,2, Pasquale Parisi3, Alberto Spalice1, Chiara Di Mario1, Benedetta Ronchi1, Alessia Russo1, Francesca De Luca1, Ida Pangallo1, Gianluca Terrin4.
Abstract
Current guidelines for preterm newborns recommend high energy nutrition soon after birth in order to limit growth retardation. However, long-term effects of this nutritional approach are still debated, and it has been demonstrated that cerebral growth depends on protein intake in early life. A negative impact of early high energy intake by parenteral nutrition (PN) has been reported for patients in critically ill conditions, observed in intensive care unit. We aimed at evaluating the impact of energy intake on cerebral growth in preterm neonates early in life. We included preterm newborns with gestational age < 32 weeks or birth weight (BW) < 1500 g. Measurement of cerebral structures was performed by cranial Ultrasonography (cUS) between 3 and 7 days of life (DOL, T0) and at 28 DOL (T1). We evaluated the relation between energy intake and cerebral growth in the first 28 DOL. We observed in 109 preterm newborns a significant (p < 0.05) negative correlation between energy intake received by PN and right caudate head growth (r = - 0.243*) and a positive correlation between total energy intake and transverse cerebellum diameter (r = 0.254*). Multivariate analysis showed that energy intake administered by enteral nutrition (EN), independently increased growth of left caudate head (β = 0.227*) and height cerebellar vermis (β = 0.415*), while PN independently affected growth of both right and left caudate head (β = - 0.164* and β = - 0.228*, respectively) and cerebellum transverse diameter (β = - 0.849*). The route of energy administration may exert different effects on cerebral growth in early life. High energy intake administered through EN seems to be positively correlated to cerebral growth; conversely, PN energy intake results in a poorer cerebral growth evaluated with cUS.Entities:
Mesh:
Year: 2021 PMID: 34531489 PMCID: PMC8445990 DOI: 10.1038/s41598-021-98088-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow-chart. DOL days of life, IVH intraventricular hemorrhage, PLV Periventricular Leukomalacia, cUS cranial ultrasound.
Clinical characteristics of study population.
| N. 109 | |
|---|---|
| Gestational age, | 29 ± 2 |
| Birth weight, g | 1288 ± 362 |
| Female, | 50 (45.9) |
| Cesarean section, | 97 (89.0) |
| Twins, | 36 (33.0) |
| Antenatal steroidsa, | 85 (78.0) |
| 5-min Apgar score | 8 ± 1 |
| pH at birth | 7.3 ± 0.1 |
| Temperature at the 1st hour, | 36.2 ± 0.5 |
| Mortality, | 2 (1.8) |
| Invasive mechanical ventilation, | 27 (24.8) |
| NEC Bell stage ≥ 2, | 4 (3.7) |
| BPD moderate grade, | 5 (4.6) |
| ROP stage ≥ 2, | 8 (7.3) |
| Sepsis proven by positive cultures, | 9 (8.3) |
| Full enteral feeding, | 14 ± 13 |
| Star of enteral nutrition, | 1 ± 1 |
| Duration of parenteral nutrition, | 14 ± 13 |
NEC necrotizing enterocolitis bell stage ≥ 2, BPD bronchopulmonary dysplasia, ROP retinopathy of prematurity.
Data were expressed as mean ± standard deviation, when not specified.
aIntramuscular steroids cycle in two doses of 12 mg over a 24-h period.
Correlations between cerebral structures linear measures and energy intake.
| Growth measures | Energy Intake in the 1st week of life | ||
|---|---|---|---|
| by EN (kcal/Kg/firstWeek) | by PN (kcal/Kg/firstWeek) | Total (kcal/Kg/firstWeek) | |
| Length | 0.048 | 0.135 | 0.218 |
| Body | 0.022 | − 0.118 | − 0.138 |
| Genu | 0.210 | − 0.129 | 0.006 |
| Splenium | 0.073 | − 0.059 | − 0.016 |
| Right | 0.117 | − 0.243* | − 0.223 |
| Left | 0.206 | − 0.074 | 0.074 |
| Transverse diameter | 0.193 | 0.070 | 0.254* |
| Vermis height | 0.098 | 0.058 | 0.159 |
| Vermis width | 0.105 | − 0.068 | − 0.002 |
(T1 − T0)/T0.
EN enteral nutrition, PN parenteral nutrition.
*p < 0.05.
Multivariate analysis of covariate influencing cerebral growth measures of the first 28 days of life in preterm newborns.
| Dependent variables° | Covariates (Model 1) | Covariates (Model 2) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Birth Weight | Gender | pH at birth | Morbidity§ | EN Energy Intake 1st w | Birth Weight | Gender | pH at birth | Morbidity§ | PN Energy intake 1st w | |
| Corpus Callosum, Length | 2.783* | − 0.707 | − 2.867 | − 3.193* | 5.745* | 1.329 | − 0.401 | − 3.565 | − 3.057* | − 4.654 |
| Corpus Callosum, Body | 0.025 | 0.000 | 0.093 | − 0.012 | − 0.019 | 0.023 | − 0.001 | 0.092 | − 0.011 | 0.001 |
| Corpus Callosum, Genu | 0.043 | 0.008 | 0.042 | 0.009 | 0.079 | 0.075 | 0.010 | 0.056 | − 0.001 | 0.040 |
| Corpus Callosum, Splenium | 0.024 | − 0.010 | − 0.047 | 0.011 | 0.072 | 0.079* | − 0.010 | − 0.022 | − 0.004 | 0.086 |
| Caudate Head Width, Right | 0.122* | 0.016 | 0.074 | 0.003 | 0.038 | 0.045 | 0.021 | 0.038 | 0.020 | − 0.164* |
| Caudate Head Width, Left | 0.031 | 0.014 | 0.071 | 0.036 | 0.277* | − 0.041 | 0.029 | 0.037 | 0.043 | − 0.228* |
| Cerebellum Transverse Diameter | 0.691* | 0.145 | − 0.050 | − 0.075 | 0.658 | 0.366 | 0.187 | − 0.203 | − 0.022 | − 0.849* |
| Cerebellar Vermis, Height | 0.069 | 0.049 | − 0.240 | 0.028 | 0.415* | 0.095 | 0.065 | − 0.230 | 0.007 | − 0.075 |
| Cerebellar Vermis, Width | 0.094 | 0.006 | 0.012 | 0.023 | 0.290 | 0.044 | 0.020 | − 0.013 | 0.024 | − 0.189 |
Growth measurement: (T1 − T0)/T0.
EN enteral nutrition, PN parenteral nutrition, 1st w first week of life, §NEC necrotizing enterocolitis and/or Sepsis proven by positive cultures and/or BPD bronchopulmonary dysplasia and/or ROP retinopathy of prematurity.
*p < 0.05.